MSCc分泌的肝细胞生长因子对人髓系白血病细胞系K562及其耐药株K562/G01增殖及药物敏感性的影响

›› 2019, Vol. 39 ›› Issue (12): 1709-1716.

MSCc分泌的肝细胞生长因子对人髓系白血病细胞系K562及其耐药株K562/G01增殖及药物敏感性的影响

马玉花¹,²,邹亚伟³,彭盛²,卢婕伦⁴,黎波⁴,何国华²,刘志刚²

1.
2. 佛山市妇幼保健院
3. 广州医学院第一附属医院儿科
4. 广州医科大学附属第一医院

收稿日期:2018-10-29 修回日期:2019-03-27 出版日期:2019-12-05 发布日期:2019-12-04
通讯作者: 邹亚伟 E-mail:zouyawei2004@163.com
基金资助:
广东省自然科学基金项目

Effects of hepatocyte growth factor secreted by bone marrow mesenchymal stem cells on proliferation and drug sensitivity of cell line K562 and resistant strain K562/G01

Received:2018-10-29 Revised:2019-03-27 Online:2019-12-05 Published:2019-12-04

摘要/Abstract

摘要： 目的研究骨髓造血微环境中间充质干细胞（MSC）分泌的肝细胞生长因子（HGF）对人白血病细胞K562及其耐药珠K562/G01细胞增殖及药物敏感性的影响。方法采用细胞贴壁法获取MSCs，选用人慢性髓系白血病急性红白血病变细胞系K562及其耐药系K562/G01。K562、K562/G01细胞分别与白血病患儿MSCs 黏附共培养，实验组为加HGF抗体组，对照组加入等量培养液，通过显微镜观察白血病细胞在MSCs层上的黏附情况并计算黏附率，MTT法检测白血病细胞增殖情况，流式细胞仪测定白血病细胞周期。在共培养各组中加入伊马替尼孵育48 h后，流式细胞仪检测白血病细胞凋亡率。结果实验组中MSCs对K562和K562/G01细胞的黏附率分别为32.4%±3.2%和38.1%±4.8%，均分别低于对照组的51.6%±3.6%和62.2%±4.9%，（P<0.05）。实验组中K652和K562/G01细胞的A值分别为（0.3102±0.039）和（0.3246±0.0358），均分别低于对照组的（0.5216±0.0467）和（0.5908±0.0034），（P<0.05）。实验组中K652及K562/G01细胞处于G0/G1期的细胞比例均高于对照组，而处于S期的细胞比例低于对照组（P<0.05）。加入伊马替尼孵育48 h后白血病细胞凋亡情况：实验组中存活细胞比例低于对照组中存活细胞比例（P<0.05）。结论 HGF可通过影响细胞黏附及细胞周期促进K562及K562/G01细胞存活与增殖，并降低伊马替尼对白血病细胞的杀伤作用。

关键词: 白血病, 肝细胞生长因子, 骨髓间充质干细胞, 儿童

Abstract: Objective To study the effect of hepatocyte growth factor (HGF) secrete by mesenchymal stem cell in bone marrow hematopoietic microenvironmen on proliferation and drug sensitivity of leukemia cell line K562 and its drug-resistant variant K562/G01.Methods The MSCs were obtained through culturing in low serum medium.K562 cells and its drug resistant K562/G01 were used. The co-culture of MSCs with leukemia cells are prepared. Leukemia Cells Cultured with MSCs. According to existence of anti-HGF antibody or not, all groups were divided into control group and experiment group.The adhesion of leukemia cells on MSCs cell layer was observed under inverted fluorescence microscope and the adhesion rates were calculated．The pro1iferation of leukemia cells in the co-culture system was observed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Cell cycle of leukemia cells in the co-culture system was investigated by flow cytometry.The survival rate of K562 cells and K562/G01 cells in the co-culture system was measured by flow cytometry after added imatinib incubation for 48 hours. Results After anti-HGF antibody was added and cultured for 24 hours, adhesion rates in experiment groups were significantly lower than those in control group(P<0.05).The pro1iferation of leukemia cells in experiment groups were all significantly lower than those in control groups in the co-culture system(P<0.05).The percentages of leukemia cells in G0/G1 phase in experiment group were higher than those in control group (P<0.05). 0n the contrary, the proportions of leukemia cells in S phase in experiment group were significantly lower than those in control group (P<0.05). Survival rate that of K562 cells and K562/G01 cells in the co-culture system after added imatinib incubation for 48 hours in experiment groups were respectively significantly lower than those in control groups (P<0.05). Conclusion The HGF promotes the cell survival and proliferation of K562 and K562/G01 cells by affecting cell adhesion and cell cycle, and reduces the killing effect of imatinib on leukemia cells.

Key words: leukemia, hepatocyte growth factor, mesenchymal stem cells, child

马玉花邹亚伟彭盛卢婕伦黎波何国华刘志刚. MSCc分泌的肝细胞生长因子对人髓系白血病细胞系K562及其耐药株K562/G01增殖及药物敏感性的影响[J]. , 2019, 39(12): 1709-1716.

[1]	刘泽昊, 王乐, 曹延延, 严小桐, 赵欣, 李文辉, 葛胜旺. 河北省手足口疾病流行病学特征及病原学分析[J]. 基础医学与临床, 2024, 44(9): 1279-1283.
[2]	张思敏, 王伟, 马明圣, 邱正庆. 75例儿童肝豆状核变性的临床及基因变异特征[J]. 基础医学与临床, 2024, 44(7): 1008-1012.
[3]	宋丽丽, 管玉洁, 马平, 李宁. 急性髓系白血病患儿柔红霉素耐药与PD-L1蛋白表达相关[J]. 基础医学与临床, 2024, 44(6): 833-839.
[4]	赵羚延, 何浏, 马艳妮, 余佳. RNA结合蛋白RBPMS调控急性髓系白血病细胞系THP-1增殖与迁移[J]. 基础医学与临床, 2024, 44(5): 619-625.
[5]	高竞溪, 赵晓妍, 朱星雨, 孙昭, 韩钦, 赵春华. BM-MSCs延缓CD8⁺初始T细胞衰老[J]. 基础医学与临床, 2024, 44(5): 683-689.
[6]	中国老年保健协会生长发育和性腺疾病分会. 儿童和青少年颅咽管瘤术后内分泌管理专家共识[J]. 基础医学与临床, 2024, 44(5): 585-598.
[7]	周昕羽, 汤继宏, 肖潇, 冯隽, 杨乐天, 徐欢, 武银银. 儿童急性B淋巴细胞白血病合并化疗诱导周围神经病变的临床特点及预后分析[J]. 基础医学与临床, 2024, 44(10): 1394-1399.
[8]	沈晨涛, 夏亚林, 盛烨萍, 褚培培, 李建琴. 儿童免疫性血小板减少症复发危险因素的调查及其预测模型的构建[J]. 基础医学与临床, 2024, 44(1): 84-91.
[9]	刘婧雯, 宋昊昕, 朱蕾. 稳定表达FIP1L1-PDGFRA及其突变体细胞株的构建和耐药性评价[J]. 基础医学与临床, 2024, 44(1): 63-68.
[10]	张亮亮, 赵程锦, 周煜虎, 曹博, 段明明, 冯阳阳. LncRNA FGD5-AS1调节miR-93-5p/BMP2轴促进人骨髓间充质干细胞成骨分化[J]. 基础医学与临床, 2023, 43(8): 1179-1185.
[11]	曾燕坤, 洪小颖, 陈清林. 下调BECN1抑制人白血病细胞系THP-1增殖、侵袭和迁移[J]. 基础医学与临床, 2023, 43(7): 1104-1109.
[12]	代子一, 马璐璐, 黄宇光. 儿童早期麻醉暴露对神经发育影响的研究进展[J]. 基础医学与临床, 2023, 43(6): 1012-1015.
[13]	翟雪莹, 王芳, 余佳. PABPC1对人单核白血病细胞系THP-1翻译活性的影响[J]. 基础医学与临床, 2023, 43(5): 751-754.
[14]	向彩霞, 黄彬涛, 郝建. 抗凋亡抑制剂维奈克拉在治疗髓系白血病的研究进展[J]. 基础医学与临床, 2023, 43(5): 833-836.
[15]	舒玲, 霍本念, 宋林. NT5C2在疾病及治疗中的研究进展[J]. 基础医学与临床, 2023, 43(5): 852-856.